The Rexis Biotech and Pharmaceutical success begins with our proprietary drug delivery platform, Fused Polymorph Nano Fiber Technology™. We are helping our partners around the globe develop the next generation of hydrophobic drug delivery systems designed to meaningfully improve existing delivery paradigms while creating novel systems for biological targets linked to both therapeutic and recreational applications.
Our team has several decades of experience in developing novel delivery systems from concept-to-clinical with a commercially proven platform that enables rapid candidate selection and accelerated CMC development for a wide range of complex modalities and needs.
Board Member: Ryan Erving, COO at Rexis Biotech
Ryan Erving is a strategic growth and implementation specialist. His expertise is in guiding startups through the process of building their teams, from pre-seed through funded series rounds.
While working with startups in the dotcom days Ryan realized that where he really excelled, and was the most excited, was working with smaller companies at the beginning of their journey. After this revelation in 2015, Ryan began consulting in the Cannabis industry where he leveraged 20+ years of business experience, his MBA and B.S. in Organizational Development to guide 30+ cannabis companies through the process of building foundational business practices, regulatory compliance, supply chain, multi-state expansion, strategic partnerships and high performing teams. Since 2019 Ryan has been the COO at Rexis Biotech helping companies and brands launch high quality edibles and beverages in the legalized cannabis industry.
For more information on Ryan’s professional background: https://www.linkedin.com/in/erving/